Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 37

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry

Simonson, Andrew W., Mongia, Agustey S., Aronson, Matthew R., Alumasa, John N., Chan, Dennis C., Lawanprasert, Atip, Howe, Michael D., Bolotsky, Adam, Mal, Tapas K., George, Christy, Ebrahimi, Aida, Baughn, Anthony D., Proctor, Elizabeth A., Keiler, Kenneth C., Medina, Scott H.·2021·Nature Biomedical Engineering

Published version of a preprint

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41551-020-00665-x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 80

  1. Blaser, M. J. Antibiotic use and its consequences for the normal microbiome. Science 352, 544–545 (2016). · DOI · Paper page
  2. Smillie, C. S. et al. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 480, 241–244 (2011). · DOI · Paper page
  3. Levy, M., Blacher, E. & Elinav, E. Microbiome, metabolites and host immunity. Curr. Opin. Microbiol. 35, 8–15 (2017). · DOI · Paper page
  4. Levy, M., Kolodziejczyk, A. A., Thaiss, C. A. & Elinav, E. Dysbiosis and the immune system. Nat. Rev. Immunol. 17, 219–232 (2017). · DOI · Paper page
  5. Spellberg, B. & Rex, J. H. The value of single-pathogen antibacterial agents. Nat. Rev. Drug Discov. 12, 963–963 (2013). · doi:10.1038/nrd3957-c1
  6. Lewis, K. Recover the lost art of drug discovery. Nature 485, 439–440 (2012). · DOI · Paper page
  7. Maxson, T. & Mitchell, D. A. Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnostics. Tetrahedron 72, 3609–3624 (2016). · DOI
  8. Brown, E. D. & Wright, G. D. Antibacterial drug discovery in the resistance era. Nature 529, 336–343 (2016). · DOI · Paper page
  9. Melander, R. J., Zurawski, D. V. & Melander, C. Narrow-spectrum antibacterial agents. Medchemcomm 9, 12–21 (2018). · DOI · Paper page
  10. Niederweis, M. Mycobacterial porins—new channel proteins in unique outer membranes. Mol. Microbiol. 49, 1167–1177 (2003). · DOI · Paper page
  11. Mahfoud, M., Sukumaran, S., Hülsmann, P., Grieger, K. & Niederweis, M. Topology of the porin MspA in the outer membrane of Mycobacterium smegmatis. J. Biol. Chem. 281, 5908–5915 (2006). · DOI
  12. Alderwick, L. J., Harrison, J., Lloyd, G. S. & Birch, H. L. The mycobacterial cell wall—peptidoglycan and arabinogalactan. Cold Spring Harb. Perspect. Med. 5, a021113 (2015). · DOI · Paper page
  13. Tossi, A., Sandri, L. & Giangaspero, A. Amphipathic, α‐helical antimicrobial peptides. Pept. Sci. 55, 4–30 (2000). · DOI · Paper page
  14. Huang, Y., Huang, J. & Chen, Y. Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell 1, 143–152 (2010). · DOI · Paper page
  15. Sharpe, H. J., Stevens, T. J. & Munro, S. A comprehensive comparison of transmembrane domains reveals organelle-specific properties. Cell 142, 158–169 (2010). · DOI · Paper page
  16. Wang, Q. et al. PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis. Science 367, 1147–1151 (2020). · DOI · Paper page
  17. Melly, G. & Purdy, G. E. MmpL proteins in physiology and pathogenesis of M. tuberculosis. Microorganisms 7, 70 (2019). · DOI
  18. Vergne, I. et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 102, 4033–4038 (2005). · DOI · Paper page
  19. Deretic, V. et al. Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell. Microbiol. 8, 719–727 (2006). · DOI · Paper page
  20. Cochran, A. G., Skelton, N. J. & Starovasnik, M. A. Tryptophan zippers: stable, monomeric β-hairpins. Proc. Natl Acad. Sci. USA 98, 5578–5583 (2001). · DOI · Paper page
  21. Liu, J., Yong, W., Deng, Y., Kallenbach, N. R. & Lu, M. Atomic structure of a tryptophan-zipper pentamer. Proc. Natl Acad. Sci. USA 101, 16156–16161 (2004). · DOI
  22. Heinz, C., Karosi, S. & Niederweis, M. High-level expression of the mycobacterial porin MspA in Escherichia coli and purification of the recombinant protein. J. Chromatogr. B 790, 337–348 (2003). · doi:10.1016/s1570-0232(03)00130-2
  23. Ragazzon, G. & Prins, L. J. Energy consumption in chemical fuel-driven self-assembly. Nat. Nanotechnol. 13, 882–889 (2018). · DOI · Paper page
  24. Lin, Y. et al. Residue-specific solvation-directed thermodynamic and kinetic control over peptide self-assembly with 1D/2D structure selection. ACS Nano 13, 1900–1909 (2019).
  25. Vandal, O. H., Nathan, C. F. & Ehrt, S. Acid resistance in Mycobacterium tuberculosis. J. Bacteriol. 191, 4714–4721 (2009). · DOI · Paper page
  26. Ramón-García, S. et al. Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. Antimicrob. Agents Chemother. 57, 2295–2303 (2013). · DOI
  27. Brown, L., Wolf, J. M., Prados-Rosales, R. & Casadevall, A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat. Rev. Microbiol. 13, 620–630 (2015). · DOI · Paper page
  28. Maitra, A. et al. Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles’ heel for the TB-causing pathogen. FEMS Microbiol. Rev. 43, 548–575 (2019). · DOI · Paper page
  29. Muheim, C. et al. Increasing the permeability of Escherichia coli using MAC13243. Sci. Rep. 7, 17629 (2017). · DOI
  30. Helander, I. & Mattila‐Sandholm, T. Fluorometric assessment of Gram‐negative bacterial permeabilization. J. Appl. Microbiol. 88, 213–219 (2000). · DOI · Paper page
  31. Eriksson, M., Nielsen, P. E. & Good, L. Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli. J. Biol. Chem. 277, 7144–7147 (2002). · DOI
  32. Halder, S. et al. Alteration of Zeta potential and membrane permeability in bacteria: a study with cationic agents. Springerplus 4, 672–672 (2015). · DOI · Paper page
  33. Yavvari, P. S. et al. Clathrin-independent killing of intracellular mycobacteria and biofilm disruptions using synthetic antimicrobial polymers. Biomacromolecules 18, 2024–2033 (2017). · DOI
  34. Butler, D., Goel, N., Goodnight, L., Tadigadapa, S. & Ebrahimi, A. Detection of bacterial metabolism in lag-phase using impedance spectroscopy of agar-integrated 3D microelectrodes. Biosens. Bioelectron. 129, 269–276 (2019). · DOI
  35. Bolotsky, A. et al. Two-dimensional materials in biosensing and healthcare: from in vitro diagnostics to optogenetics and beyond. ACS Nano 13, 9781–9810 (2019). · DOI · Paper page
  36. Inoue, S. et al. Dielectrophoretic characterization of antibiotic-treated Mycobacterium tuberculosis complex cells. Anal. Bioanal. Chem. 407, 7673–7680 (2015). · DOI
  37. Perera, A. S., Wang, H., Shrestha, T. B., Troyer, D. L. & Bossmann, S. H. Nanoscopic surfactant behavior of the porin MspA in aqueous media. Beilstein J. Nanotechnol. 4, 278–284 (2013). · doi:10.3762/bjnano.4.30
  38. Hu, B. et al. Polyphenol-binding amyloid fibrils self-assemble into reversible hydrogels with antibacterial activity. ACS Nano 12, 3385–3396 (2018). · DOI · Paper page
  39. Torrent, M., Pulido, D., Nogués, M. V. & Boix, E. Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation. PLoS Pathog. 8, e1003005 (2012). · DOI
  40. Truant, J., Brett, W. & Thomas, W. Jr Fluorescence microscopy of tubercle bacilli stained with auramine and rhodamine. Henry Ford. Hosp. Med. J. 10, 287–296 (1962).
  41. Danilchanka, O., Pavlenok, M. & Niederweis, M. Role of porins for uptake of antibiotics by Mycobacterium smegmatis. Antimicrob. Agents Chemother. 52, 3127–3134 (2008). · DOI
  42. Chairatana, P. & Nolan, E. M. Molecular basis for self-assembly of a human host-defense peptide that entraps bacterial pathogens. J. Am. Chem. Soc. 136, 13267–13276 (2014). · DOI
  43. Chairatana, P. & Nolan, E. M. Human α-defensin 6: a small peptide that self-assembles and protects the host by entangling microbes. Acc. Chem. Res. 50, 960–967 (2017). · DOI
  44. Schroeder, B. et al. Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide. Mucosal Immunol. 8, 661–671 (2015). · DOI
  45. Vetterli, S. U. et al. Thanatin targets the intermembrane protein complex required for lipopolysaccharide transport in Escherichia coli. Sci. Adv. 4, eaau2634 (2018). · DOI · Paper page
  46. Robinson, J. A. Folded synthetic peptides and other molecules targeting outer membrane protein complexes in Gram-negative bacteria. Front Chem. 7, 45–45 (2019). · DOI
  47. Luther, A. et al. Chimeric peptidomimetic antibiotics against Gram-negative bacteria. Nature 576, 452–458 (2019). · DOI · Paper page
  48. Levitt, M. Conformational preferences of amino acids in globular proteins. Biochemistry 17, 4277–4285 (1978). · DOI · Paper page
  49. Gehman, J. D. et al. Effect of antimicrobial peptides from Australian tree frogs on anionic phospholipid membranes. Biochemistry 47, 8557–8565 (2008). · DOI
  50. Jiang, Z. et al. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α-helical cationic antimicrobial peptides. Biopolymers 90, 369–383 (2008). · DOI · Paper page
  51. Mikut, R. et al. Improving short antimicrobial peptides despite elusive rules for activity. Biochim. Biophys. Acta, Biomembr. 1858, 1024–1033 (2016). · DOI
  52. Rekdal, Ø. et al. Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity. J. Biol. Chem. 287, 233–244 (2012). · DOI
  53. Medina, S. H. et al. An intrinsically disordered peptide facilitates non-endosomal cell entry. Angew. Chem. Int. Ed. 55, 3369–3372 (2016). · DOI
  54. Rath, P. et al. Cord factor (trehalose 6,6′-dimycolate) forms fully stable and non-permeable lipid bilayers required for a functional outer membrane. Biochim. Biophys. Acta, Rev. Biomembr. 1828, 2173–2181 (2013). · DOI
  55. Epand, R. F., Savage, P. B. & Epand, R. M. Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (ceragenins). Biochim. Biophys. Acta Biomembr. 1768, 2500–2509 (2007). · DOI
  56. Lombardi, L. et al. Antimicrobial peptides at work: interaction of myxinidin and its mutant WMR with lipid bilayers mimicking the P. aeruginosa and E. coli membranes. Sci. Rep. 7, 44425–44425 (2017). · doi:10.1038/srep44425
  57. Zehethofer, N. et al. Lipid analysis of airway epithelial cells for studying respiratory diseases. Chromatographia 78, 403–413 (2015). · DOI
  58. Zhang, Y., Zhang, H. & Sun, Z. Susceptibility of Mycobacterium tuberculosis to weak acids. J. Antimicrob. Chemother. 52, 56–60 (2003). · DOI
  59. Avitabile, C., D’Andrea, L. D. & Romanelli, A. Circular dichroism studies on the interactions of antimicrobial peptides with bacterial cells. Sci. Rep. 4, 4293–4293 (2014). · DOI
  60. Tao, L. et al. Probing the amyloid peptide–membrane interaction using a liposome model system. J. Self-Assem. Mol. Electron. 4, 1–18 (2016). · doi:10.13052/jsame2245-4551.2016.001
  61. Dokholyan, N. V., Buldyrev, S. V., Stanley, H. E. & Shakhnovich, E. I. Discrete molecular dynamics studies of the folding of a protein-like model. Fold. Des. 3, 577–587 (1998). · DOI · Paper page
  62. Proctor, E. A., Ding, F. & Dokholyan, N. V. Discrete molecular dynamics. WIREs Comput. Mol. Sci. 1, 80–92 (2011). · DOI
  63. Ding, F., Tsao, D., Nie, H. & Dokholyan, N. V. Ab initio folding of proteins with all-atom discrete molecular dynamics. Structure 16, 1010–1018 (2008). · DOI · Paper page
  64. Ding, F. & Dokholyan, N. V. Emergence of protein fold families through rational design. PLoS Comput. Biol. 2, e85 (2006). · DOI · Paper page
  65. Lazaridis, T. & Karplus, M. Effective energy function for proteins in solution. Proteins Struct. Funct. Bioinf. 35, 133–152 (1999). · DOI · Paper page
  66. Ding, F., Borreguero, J. M., Buldyrey, S. V., Stanley, H. E. & Dokholyan, N. V. Mechanism for the α‐helix to β‐hairpin transition. Proteins Struct. Funct. Bioinf. 53, 220–228 (2003). · DOI · Paper page
  67. Sugita, Y. & Okamoto, Y. Replica-exchange molecular dynamics method for protein folding. Chem. Phys. Lett. 314, 141–151 (1999). · DOI · Paper page
  68. Okamoto, Y. Generalized-ensemble algorithms: enhanced sampling techniques for Monte Carlo and molecular dynamics simulations. J. Mol. Graph. Model. 22, 425–439 (2004). · DOI · Paper page
  69. Feig, M., Karanicolas, J. & Brooks, C. L. III MMTSB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology. J. Mol. Graph. Model. 22, 377–395 (2004). · DOI · Paper page
  70. Kumar, S., Rosenberg, J. M., Bouzida, D., Swendsen, R. H. & Kollman, P. A. The weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method. J. Comput. Chem. 13, 1011–1021 (1992). · DOI · Paper page
  71. Coyne, J., Davis, B., Kauffman, D., Zhao, N. & Wang, Y. Polymer microneedle mediated local aptamer delivery for blocking the function of vascular endothelial growth factor. ACS Biomater. Sci. Eng. 3, 3395–3403 (2017). · DOI
  72. Burch, J. M., Mashayekh, S., Wykoff, D. D. & Grimes, C. L. Bacterial derived carbohydrates bind Cyr1 and trigger hyphal growth in Candida albicans. ACS Infect. Dis. 4, 53–58 (2018). · DOI
  73. Date, T., Sekine, J., Matsuno, H. & Serizawa, T. Polymer-binding peptides for the noncovalent modification of polymer surfaces: effects of peptide density on the subsequent immobilization of functional proteins. ACS Appl. Mater. Interfaces 3, 351–359 (2011). · doi:10.1021/am100970w
  74. Sudji, I. R., Subburaj, Y., Frenkel, N., García-Sáez, A. J. & Wink, M. Membrane disintegration caused by the steroid saponin digitonin is related to the presence of cholesterol. Molecules 20, 20146–20160 (2015). · doi:10.3390/molecules201119682
  75. Bishop, J. G., Schanbacher, F., Ferguson, L. C. & Smith, K. L. In vitro growth inhibition of mastitis-causing coliform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo-lactoferin. Infect. Immun. 14, 911–918 (1976). · DOI
  76. Xie, Z. et al. Immune cell-mediated biodegradable theranostic nanoparticles for melanoma targeting and drug delivery. Small 13, 1603121 (2017). · DOI
  77. Singh, B., Saqib, M., Gupta, A., Kumar, P. & Bhaskar, S. Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages. PLoS ONE 12, e0189606 (2017). · DOI
  78. Iyoda, T. et al. A novel mechanism underlying the basic defensive response of macrophages against Mycobacterium infection. J. Immunol. 192, 4254–4262 (2014). · DOI
  79. Jo, S. H. et al. Calreticulin modulates the intracellular survival of mycobacteria by regulating ER-stress-mediated apoptosis. Oncotarget 8, 58686 (2017). · DOI
  80. Xu, X. et al. Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance. Sci. Rep. 8, 7237 (2018). · DOI

Metadata

Authors
Simonson, A. W., Mongia, A. S., Aronson, M. R., Alumasa, J. N., Chan, D. C., Lawanprasert, A., Howe, M. D., Bolotsky, A., Mal, T. K., George, C., Ebrahimi, A., Baughn, A. D., Proctor, E. A., Keiler, K. C., & Medina, S. H.
Venue
Nature Biomedical Engineering
Published
2021-01-04
Volume
5
Issue
5
Pages
467-480
ISSN
2157-846X
Cited by
37
References
3
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | National Institutes of Health (AI123146)
  • Pennsylvania State University - Huck Institutes of Life Sciences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry. https://app.cochat.ai/papers/10.1038/s41551-020-00665-x
The paper
Simonson, A. W., Mongia, A. S., Aronson, M. R., Alumasa, J. N., Chan, D. C., Lawanprasert, A., Howe, M. D., Bolotsky, A., Mal, T. K., George, C., Ebrahimi, A., Baughn, A. D., Proctor, E. A., Keiler, K. C., & Medina, S. H. (2021). Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-020-00665-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.